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Experiments that exposed inﬂ  uenza virus (H5N1)–in-
fected cats to susceptible dogs did not result in intraspe-
cies or interspecies transmission. Infected dogs showed in-
creased body temperatures, viral RNA in pharyngeal swabs, 
and seroconversion but not fatal disease.
H
ighly pathogenic avian inﬂ  uenza (HPAI) virus (H5N1) 
has spread across Asia, Europe, and Africa. Transmis-
sion of the virus to felids has been repeatedly reported (1–
4). Investigations also indicate virus transmission to dogs. 
A fatal infection was documented in Thailand (5,6). In cen-
tral Thailand, seroprevalence of ≈25% among 629 village 
dogs was reported (7). The virus was also detected in 2 
dogs on Bali (8). The often close contact between dogs and 
humans raises questions about the zoonotic potential and 
the role of dogs in transmission and adaptation of inﬂ  uenza 
virus (H5N1) to mammals.
The Study
Experiments were performed on 2 groups of animals 
housed in different rooms in the high-containment animal 
facility (Biosafety Level 3+) at the Friedrich-Loefﬂ  er-In-
stitut using the highly pathogenic inﬂ  uenza virus (H5N1) 
strain A/cat/Germany/R606/2006  (2,9). All experiments 
were approved by the ethics committee. The ﬁ  rst group 
comprised 5 dogs and 3 cats; 3 cats and 3 dogs were in the 
second group. The dogs (beagles, 10–12 weeks of age) were 
obtained from Harlan Laboratories (Borchen, Germany). 
The cats (8–10 months of age) were obtained from Charles 
River Laboratories (Dublin, Ireland). All animals were se-
ronegative to inﬂ  uenza by ELISA (Pourquier Blocking AI 
type A (Rhone Mtrieux, France) and negative to inﬂ  uenza 
H5 antigen in hemagglutination-inhibition assays (HI).
In the ﬁ  rst group of animals, 4 dogs were inoculated 
oculo-nasopharyngeally with 106 50% egg infectious dose 
(EID50). From day 1 postinfection (p.i.) onwards, 1 unin-
fected dog and 3 uninfected cats were housed in the same 
containment room. The cats had the possibility of withdraw-
ing and hiding, but they could also have direct contact with 
the dogs through 1 part of the cage fence. During the study 
the cats frequently had direct nose-to-nose contact with 
the dogs. For a realistic contact exposure setting, the cats 
were fed by using the dogs’ food and water bowls without 
prior cleaning. In the second group, 3 cats were inoculated 
oculo-nasopharyngeally with 106 EID50. Three uninfected 
dogs were housed in the same containment room. Direct 
contact between the animals was similarly enabled as for 
group 1, and contact again occurred frequently. Two cats 
and 2 dogs housed in a separate room served as negative 
controls. Animals were monitored by physical examination 
and for viral excretion for 21 days by using pharyngeal and 
rectal swabs. 
Conjunctivitis and elevated body temperatures (39.2°C 
to 39.7°C) developed within 2 days p.i. in all inoculated 
dogs (group 1). On day 4 p.i., the conjunctivitis had re-
solved and only 2 dogs had body temperatures >39°C. By 
day 6 p.i., body temperatures of all animals had declined to 
<39°C. No additional clinical signs were observed.
Viral RNA was detected in pharyngeal and rectal 
swabs by real-time reverse transcriptase–PCR (RT-PCR), 
according to the method of Spackman et al. (10). Infec-
tious virus was detected by titration of swab ﬂ  uid in MDCK 
cells. Among the pharyngeal and rectal swabs taken at days 
0, 2, 4, 6, and 18 p.i., only the pharyngeal swabs taken on 
day 2 p.i. from 3 of the inoculated dogs were positive by 
RT-PCR. No infectious virus was isolated. Plasma and pe-
ripheral blood mononuclear cell (PBMC) samples taken on 
day 4 p.i. were negative for viral RNA.
One negative control dog and 2 inoculated dogs were 
euthanized on day 10 p.i. Sera derived from these animals 
were negative in the ELISA and HI tests. The serum of 
1 dog euthanized on day 21 p.i., however, was positive 
in ELISA and in HI testing with a titer of 16. Pharyngeal 
swabs from this dog were also positive by RT-PCR (Ta-
ble). At necropsy, no gross lesions were present that could 
be attributed to the inﬂ  uenza infection. Histopathologic ex-
amination of the liver showed a scant lymphocytic peripor-
tal inﬁ  ltration in dog no. 3. Inﬂ  uenza virus nucleoprotein 
could not be detected by immunohistochemical tests in tra-
chea, lungs, liver, kidney, adrenals, thyroid, spleen, lymph 
nodes, or thymus. Antibodies did not develop in the second 
dog, euthanized on day 21 p.i. This animal also never tested 
positive for viral RNA in swab samples by RT-PCR.
Sera of the inoculated dogs were investigated biochemi-
cally for all enzymes that could be analyzed with a FUJI 
DRI-CHEM 3500 i (Sysmex, Leipzig, Germany). Elevated 
liver enzymes have been reported in cats that were naturally 
infected with inﬂ  uenza virus (H5N1) (2). Two dogs showed 
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increased aspartate aminotransferase (AST) values up to 110 
U/L (reference values 33–52 U/L) on day 4 p.i. These dogs 
also showed elevated body temperature on days 2 and 4 p.i., 
and viral RNA was detected in pharyngeal swabs on day 2 
p.i. Dog no. 2 (Table) also showed elevated creatine phos-
phokinase (CPK) values up to 441 U/L (reference values 
54–361 U/L) on day 4 p.i. The cause of the elevated AST 
and CPK levels noted on day 4 p.i. could have been nonspe-
ciﬁ  c muscle injury. This dog was euthanized on day 10; no 
muscle injury was observed at necropsy.
The uninoculated dog housed with the infected dogs, 
as well as the 3 uninfected contact cats in group 1, never 
showed clinical symptoms. None of the pharyngeal and 
rectal swab samples, PBMC, or sera derived from these 
contact animals was positive by RT-PCR. No speciﬁ  c anti-
bodies were detected. Clearly, the virus was not transmitted 
to the contact dog and cats.
In the second group of animals, severe symptoms—
including high body temperatures (>40°C), decreased ac-
tivity, conjunctivitis, and labored breathing within 2 days 
p.i. similar to recent reports about inﬂ  uenza virus (H5N1) 
infections of cats (11,12)—developed in all infected cats. 
The cats excreted virus through the respiratory and diges-
tive tract. Viral titers quantiﬁ  ed in the pharyngeal swabs 
reached 50% tissue culture infectious dose 105 between 
days 2 and 4 p.i. Two animals were euthanized because of 
their symptoms within 5 days p.i. The third infected cat re-
covered and had HI titers of 64 within 2 weeks p.i. No clini-
cal symptoms developed in the 3 contact dogs, and pharyn-
geal swabs, PBMC, and sera were negative by RT-PCR. 
Speciﬁ  c antibodies did not develop in the dogs (Table).
Conclusions
Dogs are susceptible to HPAI virus (H5N1) infection. 
In our study, they reacted with a transient rise in body tem-
perature and in some instances with speciﬁ  c antibodies. 
Viral RNA was detected in pharyngeal swabs. Infectious 
virus could not be reisolated, and transmission of virus 
to a contact dog and cats did not occur. Contact exposure 
experiments of inﬂ  uenza virus (H5N1)–infected cats with 
uninfected dogs did not result in interspecies transmission. 
The different outcome of infection with the same dose of 
inﬂ  uenza virus (H5N1) suggests that cats are more suscep-
tible than dogs to disease. However, the experiments were 
performed with healthy animals; concurrent infections, im-
paired immune functions, and changing viral characteris-
tics might lead to aggravated infections. Also, since some 
dog breeds are genetically predisposed for certain viral and 
bacterial diseases, other breeds might be more susceptible 
to inﬂ  uenza virus (H5N1) infection (e.g., equine inﬂ  uenza 
virus [H3N8] caused disease predominantly in small groups 
of dogs of particular breeds, including greyhounds [13]). 
Therefore, dogs may have a role in adaptation of HPAI vi-
rus (H5N1) to mammals and its subsequent transmission 
to humans.
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Table. Course of experimental influenza virus (H5N1) infection of dogs and in-contact animals* 
Body temperature (dpi)  Pharyngeal swab (dpi)  Antibodies
Dog no.  EID50 0  2  4  6  0 2 4 6 
Euthanized
(dpi) HI ELISA 
1 10
6 38.5 39.2 38.8 38.8 – + – –  10  –  (+)†
2 10
6 38.4 39.7 39.1 38.8 – + – –  10  –  (+)‡
3 10
6 38.5 39.3 38.6 38.4 – + – –  21  16  + 
4 10
6 38.7 39.3 39.1 38.6 – – – –  21  –  – 
5 (dog contact)  0  38.3 38.4 38.0 38.7 – – – –  21  –  – 
6 (cat contact)  0  38.4 38.2 38.4 38.5 – – – –  21  –  – 
7 (cat contact)  0  38.3 38.5 38.6 38.8 – – – –  21  –  – 
8 (cat contact)  0  38.4 38.5 38.2 38.3 – – – –  21  –  – 
9 (neg. control)  0  38.4 38.2 38.7 37.8 – – – –  21  –  – 
10 (neg. control)  0  38.3 38.6 38.8 38.0 – – – –  21  –  – 
*Elevated body temperatures (above 39°C) are underlined. Real time reverse transcription–PCR results are given as – (cycle threshold [ct] values >38)
and + (ct values 31–38). Animal serum samples were examined by hemagglutination-inhibition (HI) using highly pathogenic influenza virus (H5N1) strain 
A/cat/Germany/R606/2006 (9) as antigen. Results are given as reciprocal titers. Competitive nucleoprotein ELISA results are given as – (inhibition <65%) 
and + (inhibition >65); EID50, 50% egg infectious dose; dpi, days postinfection.  
†Serum from dog no. 1 on dpi 10 showed 39.4% inhibition.
‡Serum from dog no. 2 showed 21.6% inhibition. References
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